A recent study reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise programs.
Published data in a major medical journal demonstrates that while obese individuals frequently drop about a fifth of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals purchasing such treatments must be aware of the potential of quick rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original weight in about 18 months.
Comparing Therapies
The study, which looked at dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with older methods.
Scientists note that people who shed pounds through dieting typically experience a slower creep back—perhaps 100 grams monthly—once they finish.
The Reason for the Quick Rebound
Experts suggest the mechanism of the injections is key to understanding the amplified rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of the hormone concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.
"Withdrawal of this GLP-1 'fix' leads to hunger is no longer kept in check, making excessive eating far more likely."
An Ongoing Condition?
The NHS suggest the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts argue that, considering the significant potential of weight regain, the treatment should be considered ongoing.
This opinion is supported by drug manufacturers, who say that the findings "emphasize the long-term character of excess weight," akin to managing diseases like hypertension.
Patient Testimonies
People who have discontinued the medication explain a powerful resurgence of appetite.
"I experienced a switch flipping and you become ravenous," described a patient.
This challenge is compounded if users have not developed permanent lifestyle or habit modifications during treatment.
Growing Interest
Figures suggest that millions of people in the UK have tried these injections in the last 12 months, with demand remaining high.
- Use is higher among women than males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a permanent cure and long-term success relies on combined lifestyle management.
